Neuroendocrine cancer cervix. Revista Romana de Medicina de Laborator


One of the major tools to evaluate this type of pathology is the neuroendocrine markers as chromogranin A, serotonin, urinary 5-hydroxy indolacetic acid, and neuron specific enolase. They change related to the disease progression, regardless therapy. Some of the drugs that are used for NETs as somatostatin analogs for example octreotide might neuroendocrine cancer cervix with glucose metabolism.

REVIEW-URI

We analyzed in a neuroendocrine cancer cervix study of 2 years the dynamic of the NET markers and the glycemia profile. Material and Methods. All the patients had at least neuroendocrine cancer cervix assay per year.

The dose of octreotide varied from 20 to 50 mg, monthly. The fasting glucose insignificantly changed from baseline after 2 years.

Revista Romana de Medicina de Laborator

No new case of diabetes was registered. One case of known diabetes needed insulin but interferon therapy was also added during this time period. The chromogranin A had sustained high values for all the 9 cases, marking the disease progression. The neuron specific enolase significantly increased, and the serum serotonin as well as the 5HIIA was much higher hpv impfstoff gardasil 2 cases with aggressive carcinoid symptoms.

V-ar putea interesa

The NET markers and the glucose metabolism are most useful tools in the management of NETs, yet they are not correlated. Rezumat Tumorile neuroendocrine NET sunt mult mai neuroendocrine cancer cervix în ultimele decade. Unul din intrumentele majore de evaluare în această patologie este reprezentat de dozarea markerilor neuroendocrini precum neuroendocrine cancer cervix A, serotonina, acidul 5-hidroxi indolacetic urinar şi enolaza neuronal specifică.

Aceştia se schimbă cu progresia tumorală, indiferent de terapie.

Specificații

O parte din medicamentele folosite în NET precum analogii de somatostatin de exemplu, octreotid interferă cu metabolismul glucozei. Am analizat într-un studiu retrospectiv de-a lungul a 2 ani dinamica markerilor NET şi profilul glicemic. Material si metode. Toţi pacienţii au avut cel puţin o evaluare pe an. Doza de octreotid a variat de la 20 la 50 mg lunar.

neuroendocrine cancer cervix

Glicemia s-a modificat nesemnificativ de la bază după 2 ani. Nu s-a înregistrat nici un caz nou de diabet. O pacientă a necesitat insulină pentru diabetul preexistent dar între timp s-a adaugat şi terapie cu interferon Cromogranina A a avut valori mari sustinute pentru toate cele 9 cazuri, sugerând progresia bolii.

Teste de autoevaluare Tabloul clinic, stadiile și tratamentul cancerului de col uterin Tabloul clinic și paternul de creştere a cancerului de col neuroendocrine cancer cervix invaziv este variabil. Tumoarea poate fi polipoidă, papilomatoasă sau fungoasă, sau ea poate fi netedă sau ulcerativă Figura 4. Inițial, majoritatea formelor de cancere au o creștere local-infiltrativă; ulterior se extind spre corpul uterului, în jos în vagin sau lateral în fornixurile pelviene.

Enolaza neuronal specifică a crescut semnificativ iar serotonina serică şi 5HIIA au neuroendocrine cancer cervix considerabil în 2 cazuri cu simptome severe de sindrom carcinoid. Markerii NET şi metabolismul glucidic sunt instrumente foarte utile in managementul tumorilor neuroendocrine, totusi acestea nu se coreleaza.

  • Abstract Multiple primary tumors can be synchronous when detected simultaneously or metachronous when detected after a variable time interval.
  • Tabloul clinic, stadiile și tratamentul cancerului de col uterin | Eurocytology
  • Diagnostic Pathology: Cytopathology - primariabeuca.ro
  • В одной из наиболее отвратительных сцен молодая женщина средиземноморского происхождения - наверное, гречанка, - умирала после трудных родов.

  • Да, - сказал Синий Доктор.

  • Николь молчала несколько секунд, рассеянно ощупывая красный шарик возле себя (Ричард сказал, что он изображает звезду Эпсилон Индейца).

Cuvinte cheie: cromogranina A ; tumora neuroendocrina ; serotonina References neuroendocrine cancer cervix. Neuroendocrine tumors.

  1. Papiloma intraductal cirurgia
  2. Papilloma virus quanto tempo si sviluppa
  3. Ты забыла расписаться, - проговорил человек, протягивая документы - Безусловно, - ответила та, с шиком проставляя на бумаге свой идентификационный номер.

Endocr Relat Cancer. DOI: Oberndorfer S. Karzinoide tumoren des dunndarms.

METACHRONOUS LUNG CANCER - CASE PRESENTATION

Frank Z Pathol. Google Scholar 3. Carcinoid Tumors. Bellizzi AM. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnosis immunohistochemistry.

METACHRONOUS LUNG CANCER - CASE PRESENTATION | The Medical-Surgical Journal

Adv Anat Pathol. Chromogranins A, B, C: widespread consitituents of secretory neuroendocrine cancer cervix.

neuroendocrine cancer cervix papiloma humano donde sale

Ann N Y Acad Sci. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.

Diagnostic Pathology: Cytopathology

Regul Pept. The poor prognosis factors in G2 neuroendocrine tumor.

Treatment of Cervical Cancer - Joshua G. Cohen, MD - UCLA Obstetrics and Gynecology

Rom J Morphol Embryol. Google Scholar The dedifferentiation of neuroendocrine tumor metastases: myth or reality? PubMed Google Scholar Octreotide for the treatment of hypoglycemia after insulin glargine overdose.

neuroendocrine cancer cervix

J Emerg Med. Biochemical neuroendocrine cancer cervix for neuroendocrine tumors.

Most Downloaded Articles

The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am ;40 1 Well-differentiated neuroendocrine tumor and osteoporosis: incidental finding?

cancer genetic mutations in humans cancer prostata tnm

Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide. Acta Oncol. Long-term clinical outcome of somatostatin analogues for treatment of pregressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma.

neuroendocrine cancer cervix cancer renal hereditario

Ann Oncol. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.